Cytokinetics, Inc. (CYTK)
63.95
+1.30
(+2.08%)
USD |
NASDAQ |
Oct 20, 16:00
63.92
-0.04
(-0.05%)
After-Hours: 20:00
Cytokinetics Gross Profit (TTM) : 46.98M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.98M |
| March 31, 2026 | 92.06M |
| December 31, 2025 | 77.91M |
| September 30, 2025 | 77.56M |
| June 30, 2025 | 76.36M |
| March 31, 2025 | 9.718M |
| December 31, 2024 | 8.943M |
| September 30, 2024 | -10.26M |
| June 30, 2024 | -9.792M |
| March 31, 2024 | -9.559M |
| December 31, 2023 | -6.233M |
| September 30, 2023 | -2.354M |
| June 30, 2023 | -0.451M |
| March 31, 2023 | 88.44M |
| December 31, 2022 | 86.19M |
| September 30, 2022 | 139.88M |
| June 30, 2022 | 139.46M |
| March 31, 2022 | 52.49M |
| December 31, 2021 | 52.91M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 9.606M |
| June 30, 2016 | 17.40M |
| March 31, 2016 | 23.80M |
| December 31, 2015 | 28.07M |
| September 30, 2015 | 40.08M |
| June 30, 2015 | 41.57M |
| March 31, 2015 | 42.84M |
| December 31, 2014 | 46.45M |
| September 30, 2014 | 49.09M |
| June 30, 2014 | 44.17M |
| March 31, 2014 | 37.39M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Bristol Myers Squibb Co. | 32.78B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| BioMarin Pharmaceutical, Inc. | 2.556B |
| Exelixis, Inc. | 2.350B |
| Ionis Pharmaceuticals, Inc. | 835.84M |